Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tape test: researchers check which bandages stick best

NCT ID NCT07136870

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 4 times

Summary

This study will test how strongly different medical tapes stick to people's skin over 24 hours. About 48 healthy volunteers aged 18 to 70 will take part. The goal is to set up a new method for measuring tape adhesion at the study site.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

41 people

The number who actually took part.

Started

Oct 2025

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The participants must meet all of the following criteria to be eligible to participate in the investigation: 1. Written informed consent to participate in the study. 2. Willingness to actively participate in the study and to come to the scheduled visits. 3. Female and/or male. 4. From 18 to 70 years of age. 5. Minimal hairiness on the back (the test area) Exclusion Criteria: * Participants meeting any of the following criteria will not be permitted to participate in the investigation: 1. Female participants: Pregnancy or lactation. 2. Drug or alcohol addiction. 3. AIDS, HIV-positive or infectious hepatitis. 4. Conditions which exclude a participation or might influence the test reaction/evaluation. 5. Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area. 6. Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years. 7. Diabetes mellitus (type 1 and 2). 8. One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension, cardiovascular diseases. 9. Active skin disease at the test area. 10. Documented allergies to dressings in particular with acrylates and natural rubber (latex). 11. Wounds, moles, tattoos, scars, irritated skin at the test area that could influence the investigation. 12. Any topical medication at the test area within the last 24 hours prior to the start of the study and/or throughout the entire course of the study. 13. Application of cosmetics (e.g. creams, lotions, sunscreens) to the test area within the last 3 days prior to start of the study. 14. Showering at the day of study start.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin (flacc scores of test subjects) after tape removal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Essity Study Site

    Mölndal, VGR, 43131, Sweden